Literature DB >> 18378514

Cancer risk in hospitalized rheumatoid arthritis patients.

K Hemminki1, X Li, K Sundquist, J Sundquist.   

Abstract

OBJECTIVES: Patients diagnosed with RA have been at an increased risk of many cancers and at a decreased risk of some cancers. We planned to revisit the theme by using a nation-wide population of RA patients.
METHODS: An RA research database was constructed by identifying hospitalized RA patients from the Hospital Discharge Register and cancer patients from the Cancer Registry. Earlier studies from Sweden have shown that some 75% of RA patients have been hospitalized at some time point. Follow-up of 42,262 RA patients was carried out from year 1980 to 2004 including separate follow-ups for shorter intervals. Standardized incidence ratios (SIRs) were calculated for cancer in RA patients by comparing with subjects without RA.
RESULTS: Many cancers were in excess in RA patients, especially Hodgkin disease, non-Hodgkin lymphoma and squamous cell skin cancer; a novel association was found for non-thyroid endocrine tumours. Colon, rectal and endometrial cancers were decreased in RA patients. When RA patients were first hospitalized after 1999, the SIRs for melanoma, squamous cell skin and upper aerodigestive tract cancers and for leukaemia were increased compared with previous periods.
CONCLUSIONS: This study, the largest so far published, quantified the increased and decreased site-specific risks of cancer in RA patients. The recent increases in the risks of squamous cell skin and upper aerodigestive tract cancers, melanoma and leukaemia call for continuous vigilance and recording of changes in treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378514     DOI: 10.1093/rheumatology/ken130

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  27 in total

1.  Family history of cancer and non-malignant diseases and risk of childhood acute lymphoblastic leukemia: a Children's Oncology Group Study.

Authors:  Heather Zierhut; Martha S Linet; Leslie L Robison; Richard K Severson; Logan Spector
Journal:  Cancer Epidemiol       Date:  2011-10-21       Impact factor: 2.984

2.  The 4q27 locus and prostate cancer risk.

Authors:  Elizabeth A Tindall; Hoa N Hoang; Melissa C Southey; Dallas R English; John L Hopper; Graham G Giles; Gianluca Severi; Vanessa M Hayes
Journal:  BMC Cancer       Date:  2010-02-25       Impact factor: 4.430

Review 3.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

4.  Melanoma and rheumatoid arthritis (brief report).

Authors:  Sarah Perkins; Martin Cohen; Elham Rahme; Sasha Bernatsky
Journal:  Clin Rheumatol       Date:  2012-01-13       Impact factor: 2.980

Review 5.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 6.  Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.

Authors:  Alla Ishchenko; Rik J Lories
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

7.  Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.

Authors:  Heather P Tarleton; Suzanne Ryan-Ibarra; Marta Induni
Journal:  J Cancer Surviv       Date:  2014-04-09       Impact factor: 4.442

8.  Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study.

Authors:  Nathalie Berghen; Laure-Anne Teuwen; Rene Westhovens; Patrick Verschueren
Journal:  Clin Rheumatol       Date:  2015-07-30       Impact factor: 2.980

9.  Subsequent brain tumors in patients with autoimmune disease.

Authors:  Kari Hemminki; Xiangdong Liu; Asta Försti; Jianguang Ji; Jan Sundquist; Kristina Sundquist
Journal:  Neuro Oncol       Date:  2013-06-11       Impact factor: 12.300

Review 10.  Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?

Authors:  George E Fragoulis; Katerina Chatzidionysiou
Journal:  Clin Rheumatol       Date:  2019-12-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.